Recent data has demonstrated that the effect of AChE inhibitors are not necessarily confined to cholinesterase inhibition but that they also improve the symptoms of AD through regulation of the processing and secretion of amyloid precursor protein (APP) [6]. The gene discussed is APP; the disease is Alzheimer disease.